CORE LABORATORIES N V Quarterly Liabilities and Equity in USD from Q2 2010 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Core Laboratories N V quarterly Liabilities and Equity history and growth rate from Q2 2010 to Q1 2023.
  • Core Laboratories N V Liabilities and Equity for the quarter ending March 31, 2023 was $594M, a 1.49% increase year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $594M +$8.7M +1.49% Mar 31, 2023 10-Q 2023-04-27
Q4 2022 $578M -$2.5M -0.43% Dec 31, 2022 10-Q 2023-04-27
Q3 2022 $570M -$16.1M -2.74% Sep 30, 2022 10-Q 2022-10-28
Q2 2022 $578M -$20.9M -3.49% Jun 30, 2022 10-Q 2022-07-28
Q1 2022 $585M +$472K +0.08% Mar 31, 2022 10-Q 2022-04-28
Q4 2021 $581M +$12.3M +2.16% Dec 31, 2021 10-K 2023-02-10
Q3 2021 $586M -$4.54M -0.77% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 $598M -$16M -2.61% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $584M -$62.2M -9.61% Mar 31, 2021 10-Q 2021-04-23
Q4 2020 $569M -$206M -26.6% Dec 31, 2020 10-K 2022-02-10
Q3 2020 $591M -$197M -25% Sep 30, 2020 10-Q 2020-10-22
Q2 2020 $614M -$167M -21.4% Jun 30, 2020 10-Q 2020-07-24
Q1 2020 $647M -$145M -18.3% Mar 31, 2020 10-Q 2020-04-24
Q4 2019 $775M +$126M +19.4% Dec 31, 2019 10-K 2021-02-08
Q3 2019 $788M +$121M +18.2% Sep 30, 2019 10-Q 2019-10-25
Q2 2019 $782M +$177M +29.2% Jun 30, 2019 10-Q 2019-07-26
Q1 2019 $792M +$195M +32.6% Mar 31, 2019 10-Q 2019-04-26
Q4 2018 $649M +$64M +10.9% Dec 31, 2018 10-K 2020-02-10
Q3 2018 $667M +$83.9M +14.4% Sep 30, 2018 10-Q 2018-10-25
Q2 2018 $605M +$21M +3.6% Jun 30, 2018 10-Q 2018-07-27
Q1 2018 $597M +$16.7M +2.88% Mar 31, 2018 10-Q 2018-04-27
Q4 2017 $585M +$11.8M +2.05% Dec 31, 2017 10-K 2019-02-11
Q3 2017 $583M +$20.6M +3.67% Sep 30, 2017 10-Q 2017-10-25
Q2 2017 $584M +$11.7M +2.04% Jun 30, 2017 10-Q 2017-07-26
Q1 2017 $580M -$6.83M -1.16% Mar 31, 2017 10-Q 2017-04-21
Q4 2016 $573M -$52.2M -8.35% Dec 31, 2016 10-K 2018-02-12
Q3 2016 $562M -$73M -11.5% Sep 30, 2016 10-Q 2016-10-21
Q2 2016 $572M -$86.9M -13.2% Jun 30, 2016 10-Q 2016-07-22
Q1 2016 $587M -$42.8M -6.79% Mar 31, 2016 10-Q 2016-04-22
Q4 2015 $625M -$48.1M -7.14% Dec 31, 2015 10-K 2017-02-10
Q3 2015 $635M -$50M -7.3% Sep 30, 2015 10-Q 2015-10-23
Q2 2015 $659M -$30.1M -4.37% Jun 30, 2015 10-Q 2015-07-27
Q1 2015 $630M -$50.4M -7.4% Mar 31, 2015 10-Q 2015-04-29
Q4 2014 $673M +$12.3M +1.86% Dec 31, 2014 10-K 2016-02-12
Q3 2014 $685M +$27.7M +4.21% Sep 30, 2014 10-Q 2014-11-04
Q2 2014 $689M +$34M +5.19% Jun 30, 2014 10-Q 2014-07-25
Q1 2014 $680M +$24.9M +3.8% Mar 31, 2014 10-Q 2014-04-25
Q4 2013 $661M +$24.5M +3.85% Dec 31, 2013 10-K 2015-02-17
Q3 2013 $657M +$18.9M +2.97% Sep 30, 2013 10-Q 2013-10-18
Q2 2013 $655M +$32.4M +5.21% Jun 30, 2013 10-Q 2013-07-19
Q1 2013 $655M +$44.8M +7.33% Mar 31, 2013 10-Q 2013-04-19
Q4 2012 $637M +$25.6M +4.2% Dec 31, 2012 10-K 2014-02-13
Q3 2012 $639M +$75.6M +13.4% Sep 30, 2012 10-Q 2012-10-19
Q2 2012 $623M +$70.4M +12.8% Jun 30, 2012 10-Q 2012-07-20
Q1 2012 $611M +$13.4M +2.24% Mar 31, 2012 10-Q 2012-04-23
Q4 2011 $611M -$39.4M -6.05% Dec 31, 2011 10-K 2013-02-19
Q3 2011 $563M -$82.1M -12.7% Sep 30, 2011 10-Q 2011-10-25
Q2 2011 $552M -$100M -15.4% Jun 30, 2011 10-Q 2011-07-29
Q1 2011 $597M Mar 31, 2011 10-Q 2011-04-22
Q4 2010 $650M Dec 31, 2010 10-K 2012-02-15
Q3 2010 $645M Sep 30, 2010 10-Q/A 2010-10-26
Q2 2010 $653M Jun 30, 2010 10-Q 2010-07-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.